Biotech
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 10/25/11 -- DelMar Pharmaceuticals today announced the initiation of the Company's planned clinical trial with its lead drug candidate, VAL-083, f ...
LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwire) -- 10/25/11 -- Sernova Corp. (TSX VENTURE: SVA), is pleased to announce it has entered into a collaboration with The Clinical Islet Transplant Program at the Universi ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwire) -- 10/24/11 -- Thallion Pharmaceuticals Inc. (TSX: TLN) announced that blinded results from the low dose cohort of its Phase II SHIGATEC study were presented at the ...
MISSION VIEJO, CA: MISSION VIEJO, CA -- (Marketwire) -- 10/24/11 -- Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company leveraging significant funding from the U.S. Department of Hea ...
BOULDER, CO: BOULDER, CO -- (Marketwire) -- 10/24/11 -- MBio Diagnostics, Inc. today announced publication of study results in the American Society for Microbiology's Journal of Clinical Microbiology (Lochh ...
OTTAWA, ONTARIO: OTTAWA, ONTARIO -- (Marketwire) -- 10/24/11 -- PharmaGap Inc. (TSX VENTURE: GAP)(OTCBB: PHRGF) ("PharmaGap" or "the Company") announced today that it has chosen ovarian cancer as ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 10/21/11 -- enGene Inc., a privately held biotechnology company headquartered in Vancouver, announced today the appointment of Dr. Richard M. Glickman, ...
MANASSAS, VA: MANASSAS, VA -- (Marketwire) -- 10/21/11 -- (PINKSHEETS: EWPI) -- Strategic partner, African Global Pharma (AGP), has now completed all regulatory requirements for production at its Sunyani, Ghana f ...
OTTAWA, ONTARIO: OTTAWA, ONTARIO -- (Marketwire) -- 10/21/11 -- PharmaGap Inc. (TSX VENTURE: GAP)(OTCBB: PHRGF) ("PharmaGap" or "the Company") announced today the final closing of a private offer ...
BERKELEY, CA: BERKELEY, CA -- (Marketwire) -- 10/21/11 -- Dynavax Technologies Corporation (NASDAQ: DVAX) announced today the expansion of its worldwide strategic alliance with GlaxoSmithKline (GSK) focused on to ...
NEW YORK, NY: The Paragon Report Provides Equity Research on Cardium Therapeutics & Oncothyreon ...
NEW YORK, NY: The Paragon Report Provides Equity Research on OXiGENE & Neoprobe Corporation ...
BOTHELL, WA: Data From Clinical Study of Marburg Candidate to Be Presented at 49th Annual Meeting of Infectious Diseases Society of America ...
DEERFIELD, IL: DEERFIELD, IL -- (Marketwire) -- 10/21/11 -- Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that the Company's chairman, president and chief executive officer, Timothy P. Walbert, is sched ...
AURORA, ON: AURORA, ON -- (Marketwire) -- 10/20/11 -- Helix BioPharma Corp. (TSX: HBP) (NYSE Amex: HBP) (FRANKFURT: HBP) today announced that it has terminated its Financial and Investor Relations Agreement wit ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 10/20/11 -- Cytokinetics, Incorporated (NASDAQ: CYTK) announced today that it is scheduled to report third quarter results on Thursday, October 27, 2011 at ...
WASHINGTON, DC: Meeting Coincides With Grand Opening of New Sanford Consortium Facility ...
LONDON, ONTARIO: COTI-2 Proven to Be Highly Selective, Orally Effective and Well Tolerated; Well Positioned for Clinical Development ...
MELBOURNE, AUSTRALIA: Dr. Paul Adlard Awarded Funding to Investigate Prevention of Age-Related Cognitive Decline ...
NEW YORK, NY: The Paragon Report Provides Equity Research on Dendreon & Cell Therapeutics ...
